LGND logo

Ligand Pharmaceuticals Incorporated (LGND) Shareholders Equity

Annual Shareholders Equity

$700.91 M
+$103.43 M+17.31%

31 December 2023

LGND Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

$841.18 M
+$65.98 M+8.51%

30 September 2024

LGND Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

LGND Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+17.3%+25.9%
3 y3 years-1.2%+3.6%
5 y5 years+25.0%-1.1%

LGND Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-14.6%+17.3%at high+40.8%
5 y5 years-14.6%+25.0%-1.1%+40.8%
alltimeall time-14.6%+734.8%-22.1%+434.9%

Ligand Pharmaceuticals Incorporated Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
$841.18 M(+8.5%)
June 2024
-
$775.20 M(-3.9%)
Mar 2024
-
$806.52 M(+15.1%)
Dec 2023
$700.91 M(+17.3%)
$700.91 M(+4.9%)
Sept 2023
-
$667.90 M(+0.5%)
June 2023
-
$664.89 M(+2.9%)
Mar 2023
-
$646.32 M(+8.2%)
Dec 2022
$597.49 M(-27.2%)
$597.49 M(-26.8%)
Sept 2022
-
$816.30 M(+1.7%)
June 2022
-
$802.37 M(+1.2%)
Mar 2022
-
$793.19 M(-3.4%)
Dec 2021
$821.16 M(+15.7%)
$821.16 M(+1.1%)
Sept 2021
-
$812.07 M(+3.2%)
June 2021
-
$786.52 M(+5.5%)
Mar 2021
-
$745.84 M(+5.1%)
Dec 2020
$709.52 M(-7.5%)
$709.52 M(+1.7%)
Sept 2020
-
$697.82 M(+0.4%)
June 2020
-
$695.00 M(+5.0%)
Mar 2020
-
$661.90 M(-13.7%)
Dec 2019
$767.23 M(+36.8%)
$767.23 M(-9.8%)
Sept 2019
-
$850.58 M(-18.3%)
June 2019
-
$1.04 B(-3.6%)
Mar 2019
-
$1.08 B(+92.5%)
Dec 2018
$560.91 M(+34.0%)
$560.91 M(-19.8%)
Sept 2018
-
$699.52 M(+12.9%)
June 2018
-
$619.81 M(+24.7%)
Mar 2018
-
$497.18 M(+18.8%)
Dec 2017
$418.65 M(+12.9%)
$418.65 M(-1.4%)
Sept 2017
-
$424.76 M(+3.8%)
June 2017
-
$409.41 M(+2.7%)
Mar 2017
-
$398.78 M(+7.5%)
Dec 2016
$370.85 M(+33.9%)
$370.85 M(+0.1%)
Sept 2016
-
$370.39 M(-5.5%)
June 2016
-
$391.92 M(-0.0%)
Mar 2016
-
$392.08 M(+41.6%)
Dec 2015
$276.91 M(+952.2%)
$276.91 M(-5.2%)
Sept 2015
-
$292.18 M(+323.1%)
June 2015
-
$69.05 M(+96.5%)
Mar 2015
-
$35.15 M(+33.6%)
Dec 2014
$26.32 M(-47.0%)
$26.32 M(-40.7%)
Sept 2014
-
$44.37 M(-30.9%)
June 2014
-
$64.17 M(-1.3%)
Mar 2014
-
$65.00 M(+31.0%)
Dec 2013
$49.61 M(+87.3%)
$49.61 M(+10.7%)
Sept 2013
-
$44.81 M(+14.1%)
June 2013
-
$39.27 M(+28.3%)
Mar 2013
-
$30.60 M(+15.5%)
Dec 2012
$26.48 M(+223.6%)
$26.48 M(+24.7%)
Sept 2012
-
$21.23 M(+15.1%)
June 2012
-
$18.45 M(-4.1%)
Mar 2012
-
$19.24 M(+135.1%)
Dec 2011
$8.19 M(-268.8%)
$8.19 M(+245.8%)
Sept 2011
-
$2.37 M(-55.6%)
June 2011
-
$5.33 M(+6.3%)
Mar 2011
-
$5.01 M(-203.3%)
Dec 2010
-$4.85 M(-229.5%)
-$4.85 M(-48.6%)
Sept 2010
-
-$9.44 M(-455.4%)
June 2010
-
$2.66 M(+23.8%)
Mar 2010
-
$2.15 M(-42.7%)
Dec 2009
$3.74 M
$3.74 M(-139.4%)
Sept 2009
-
-$9.50 M(-22.5%)
DateAnnualQuarterly
June 2009
-
-$12.26 M(-16.6%)
Mar 2009
-
-$14.70 M(+41.8%)
Dec 2008
-$10.37 M(-135.6%)
-$10.37 M(-630.5%)
Sept 2008
-
$1.95 M(-89.7%)
June 2008
-
$19.02 M(-22.5%)
Mar 2008
-
$24.53 M(-15.7%)
Dec 2007
$29.11 M(+6.4%)
$29.11 M(+10.7%)
Sept 2007
-
$26.29 M(-23.2%)
June 2007
-
$34.23 M(-40.4%)
Mar 2007
-
$57.40 M(+109.9%)
Dec 2006
$27.35 M(-124.8%)
$27.35 M(-110.9%)
Sept 2006
-
-$251.19 M(+5.3%)
June 2006
-
-$238.50 M(+6.3%)
Mar 2006
-
-$224.36 M(+103.2%)
Dec 2005
-$110.42 M(+46.6%)
-$110.42 M(+1.8%)
Sept 2005
-
-$108.41 M(+5.9%)
June 2005
-
-$102.39 M(+9.0%)
Mar 2005
-
-$93.96 M(+24.7%)
Dec 2004
-$75.32 M(+100.6%)
-$75.32 M(-283.9%)
Sept 2004
-
$40.96 M(-14.7%)
June 2004
-
$48.00 M(-20.5%)
Mar 2004
-
$60.37 M(-260.8%)
Dec 2003
-$37.55 M(-150.7%)
-$37.55 M(-160.0%)
Sept 2003
-
$62.60 M(+131.3%)
June 2003
-
$27.06 M(-28.8%)
Mar 2003
-
$38.02 M(-48.6%)
Dec 2002
$74.02 M(-227.9%)
$74.02 M(-8.2%)
Sept 2002
-
$80.67 M(-7.3%)
June 2002
-
$87.01 M(+180.5%)
Mar 2002
-
$31.02 M(-153.6%)
Dec 2001
-$57.88 M(+5.0%)
-$57.88 M(+10.9%)
Sept 2001
-
-$52.17 M(+14.3%)
June 2001
-
-$45.63 M(+19.4%)
Mar 2001
-
-$38.23 M(-30.7%)
Dec 2000
-$55.13 M(+115.3%)
-$55.13 M(+81.7%)
Sept 2000
-
-$30.34 M(+80.5%)
June 2000
-
-$16.81 M(+33.0%)
Mar 2000
-
-$12.64 M(-50.6%)
Dec 1999
-$25.60 M(+124.6%)
-$25.60 M(-43.1%)
Sept 1999
-
-$45.00 M(+48.5%)
June 1999
-
-$30.30 M(+91.8%)
Mar 1999
-
-$15.80 M(+38.6%)
Dec 1998
-$11.40 M(-133.2%)
-$11.40 M(-256.2%)
Sept 1998
-
$7.30 M(-46.7%)
June 1998
-
$13.70 M(-39.9%)
Mar 1998
-
$22.80 M(-33.5%)
Dec 1997
$34.30 M(-0.6%)
$34.30 M(+113.0%)
Sept 1997
-
$16.10 M(-30.3%)
June 1997
-
$23.10 M(-28.3%)
Mar 1997
-
$32.20 M(-6.7%)
Dec 1996
$34.50 M(+22.8%)
$34.50 M(+305.9%)
Sept 1996
-
$8.50 M(-33.1%)
June 1996
-
$12.70 M(-42.8%)
Mar 1996
-
$22.20 M(-21.0%)
Dec 1995
$28.10 M(+6.8%)
$28.10 M(-14.1%)
Sept 1995
-
$32.70 M(+25.3%)
Mar 1995
-
$26.10 M(-0.8%)
Dec 1994
$26.30 M
$26.30 M(-19.6%)
Sept 1994
-
$32.70 M(+14.7%)
June 1994
-
$28.50 M(-20.6%)
Mar 1994
-
$35.90 M

FAQ

  • What is Ligand Pharmaceuticals Incorporated annual stockholders equity?
  • What is the all time high annual shareholders equity for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated annual shareholders equity year-on-year change?
  • What is Ligand Pharmaceuticals Incorporated quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated quarterly shareholders equity year-on-year change?

What is Ligand Pharmaceuticals Incorporated annual stockholders equity?

The current annual shareholders equity of LGND is $700.91 M

What is the all time high annual shareholders equity for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high annual stockholders equity is $821.16 M

What is Ligand Pharmaceuticals Incorporated annual shareholders equity year-on-year change?

Over the past year, LGND annual stockholders equity has changed by +$103.43 M (+17.31%)

What is Ligand Pharmaceuticals Incorporated quarterly stockholders equity?

The current quarterly shareholders equity of LGND is $841.18 M

What is the all time high quarterly shareholders equity for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high quarterly stockholders equity is $1.08 B

What is Ligand Pharmaceuticals Incorporated quarterly shareholders equity year-on-year change?

Over the past year, LGND quarterly stockholders equity has changed by +$173.28 M (+25.94%)